Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Estimation of genetic parameters for growth and carcass traits in turbot (Scophthalmus maximus).

Schlicht K, Krattenmacher N, Lugert V, Schulz C, Thaller G, Tetens J.

Arch Anim Breed. 2019 May 6;62(1):265-273. doi: 10.5194/aab-62-265-2019. eCollection 2019.

2.

Higher BDNF plasma levels are associated with a normalization of memory dysfunctions during an antidepressant treatment.

Engelmann J, Wagner S, Wollschläger D, Kaaden S, Schlicht KF, Dreimüller N, Braus DF, Müller MB, Tüscher O, Frieling H, Tadić A, Lieb K.

Eur Arch Psychiatry Clin Neurosci. 2019 Mar 30. doi: 10.1007/s00406-019-01006-z. [Epub ahead of print]

PMID:
30929060
3.

The metabolic network coherence of human transcriptomes is associated with genetic variation at the cadherin 18 locus.

Schlicht K, Nyczka P, Caliebe A, Freitag-Wolf S, Claringbould A, Franke L, Võsa U; BIOS Consortium, Kardia SLR, Smith JA, Zhao W, Gieger C, Peters A, Prokisch H, Strauch K; KORA Study Group, Baurecht H, Weidinger S, Rosenstiel P, Hütt MT, Knecht C, Szymczak S, Krawczak M.

Hum Genet. 2019 Apr;138(4):375-388. doi: 10.1007/s00439-019-01994-x. Epub 2019 Mar 9.

4.

Genetic Imbalance Is Associated With Functional Outcome After Ischemic Stroke.

Pfeiffer D, Chen B, Schlicht K, Ginsbach P, Abboud S, Bersano A, Bevan S, Brandt T, Caso V, Debette S, Erhart P, Freitag-Wolf S, Giacalone G, Grau AJ, Hayani E, Jern C, Jiménez-Conde J, Kloss M, Krawczak M, Lee JM, Lemmens R, Leys D, Lichy C, Maguire JM, Martin JJ, Metso AJ, Metso TM, Mitchell BD, Pezzini A, Rosand J, Rost NS, Stenman M, Tatlisumak T, Thijs V, Touzé E, Traenka C, Werner I, Woo D, Del Zotto E, Engelter ST, Kittner SJ, Cole JW, Grond-Ginsbach C, Lyrer PA, Lindgren A; CADISP; GISCOME; SiGN studies; and ISGC.

Stroke. 2019 Feb;50(2):298-304. doi: 10.1161/STROKEAHA.118.021856.

PMID:
30661490
5.

Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting.

Chauhan G, Adams HHH, Satizabal CL, Bis JC, Teumer A, Sargurupremraj M, Hofer E, Trompet S, Hilal S, Smith AV, Jian X, Malik R, Traylor M, Pulit SL, Amouyel P, Mazoyer B, Zhu YC, Kaffashian S, Schilling S, Beecham GW, Montine TJ, Schellenberg GD, Kjartansson O, Guðnason V, Knopman DS, Griswold ME, Windham BG, Gottesman RF, Mosley TH, Schmidt R, Saba Y, Schmidt H, Takeuchi F, Yamaguchi S, Nabika T, Kato N, Rajan KB, Aggarwal NT, De Jager PL, Evans DA, Psaty BM, Rotter JI, Rice K, Lopez OL, Liao J, Chen C, Cheng CY, Wong TY, Ikram MK, van der Lee SJ, Amin N, Chouraki V, DeStefano AL, Aparicio HJ, Romero JR, Maillard P, DeCarli C, Wardlaw JM, Hernández MDCV, Luciano M, Liewald D, Deary IJ, Starr JM, Bastin ME, Muñoz Maniega S, Slagboom PE, Beekman M, Deelen J, Uh HW, Lemmens R, Brodaty H, Wright MJ, Ames D, Boncoraglio GB, Hopewell JC, Beecham AH, Blanton SH, Wright CB, Sacco RL, Wen W, Thalamuthu A, Armstrong NJ, Chong E, Schofield PR, Kwok JB, van der Grond J, Stott DJ, Ford I, Jukema JW, Vernooij MW, Hofman A, Uitterlinden AG, van der Lugt A, Wittfeld K, Grabe HJ, Hosten N, von Sarnowski B, Völker U, Levi C, Jimenez-Conde J, Sharma P, Sudlow CLM, Rosand J, Woo D, Cole JW, Meschia JF, Slowik A, Thijs V, Lindgren A, Melander O, Grewal RP, Rundek T, Rexrode K, Rothwell PM, Arnett DK, Jern C, Johnson JA, Benavente OR, Wasssertheil-Smoller S, Lee JM, Wong Q, Mitchell BD, Rich SS, McArdle PF, Geerlings MI, van der Graaf Y, de Bakker PIW, Asselbergs FW, Srikanth V, Thomson R, McWhirter R, Moran C, Callisaya M, Phan T, Rutten-Jacobs LCA, Bevan S, Tzourio C, Mather KA, Sachdev PS, van Duijn CM, Worrall BB, Dichgans M, Kittner SJ, Markus HS, Ikram MA, Fornage M, Launer LJ, Seshadri S, Longstreth WT Jr, Debette S; Stroke Genetics Network (SiGN), the International Stroke Genetics Consortium (ISGC), METASTROKE, Alzheimer's Disease Genetics Consortium (ADGC), and the Neurology Working Group of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium.

Neurology. 2019 Jan 16. pii: 10.1212/WNL.0000000000006851. doi: 10.1212/WNL.0000000000006851. [Epub ahead of print]

6.

BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response.

Lieb K, Dreimüller N, Wagner S, Schlicht K, Falter T, Neyazi A, Müller-Engling L, Bleich S, Tadić A, Frieling H.

Front Psychiatry. 2018 Oct 26;9:511. doi: 10.3389/fpsyt.2018.00511. eCollection 2018.

7.

'When you're it': a qualitative study exploring the rural nurse experience of managing acute mental health presentations.

Beks H, Healey C, Schlicht KG.

Rural Remote Health. 2018 Aug;18(3):4616. doi: 10.22605/RRH4616. Epub 2018 Aug 7.

8.

snRPN controls the ability of neurons to regenerate axons.

Mertsch S, Schlicht K, Melkonyan H, Schlatt S, Thanos S.

Restor Neurol Neurosci. 2018;36(1):31-43. doi: 10.3233/RNN-170780.

PMID:
29439367
9.

Plasma brain-derived neurotrophic factor (pBDNF) and executive dysfunctions in patients with major depressive disorder.

Wagner S, Kayser S, Engelmann J, Schlicht KF, Dreimüller N, Tüscher O, Müller-Dahlhaus F, Braus DF, Tadić A, Neyazi A, Frieling H, Lieb K.

World J Biol Psychiatry. 2019 Sep;20(7):519-530. doi: 10.1080/15622975.2018.1425478. Epub 2018 Feb 2.

PMID:
29334322
10.

Mental health academics in rural and remote Australia.

Pierce D, Little F, Bennett-Levy J, Isaacs AN, Bridgman H, Lutkin SJ, Carey TA, Schlicht KG, McCabe-Gusta ZP, Martin E, Martinez LA.

Rural Remote Health. 2016 Jul-Sep;16(3):3793. Epub 2016 Sep 22.

11.

The Amount of Mitochondrial DNA in Blood Reflects the Course of a Depressive Episode.

Nicod J, Wagner S, Vonberg F, Bhomra A, Schlicht KF, Tadic A, Mott R, Lieb K, Flint J.

Biol Psychiatry. 2016 Sep 15;80(6):e41-e42. doi: 10.1016/j.biopsych.2015.12.019. Epub 2015 Dec 30. No abstract available.

PMID:
26917357
12.

Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression--The EMC trial.

Tadić A, Wachtlin D, Berger M, Braus DF, van Calker D, Dahmen N, Dreimüller N, Engel A, Gorbulev S, Helmreich I, Kaiser AK, Kronfeld K, Schlicht KF, Tüscher O, Wagner S, Hiemke C, Lieb K.

Eur Neuropsychopharmacol. 2016 Apr;26(4):705-16. doi: 10.1016/j.euroneuro.2016.02.003. Epub 2016 Feb 9.

PMID:
26899588
13.

A 48-year-old woman with panic attacks.

Schlicht KF, Mann K, Jungmann F, Kaes J, Post F, Münzel T, Lieb K.

Lancet. 2014 Jul 19;384(9939):280. doi: 10.1016/S0140-6736(14)60882-5. No abstract available.

PMID:
25042236
15.

Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression.

Tadić A, Müller-Engling L, Schlicht KF, Kotsiari A, Dreimüller N, Kleimann A, Bleich S, Lieb K, Frieling H.

Mol Psychiatry. 2014 Mar;19(3):281-3. doi: 10.1038/mp.2013.58. Epub 2013 May 14. No abstract available.

PMID:
23670489
16.

Severe tremor after cotrimoxazole-induced elevation of venlafaxine serum concentrations in a patient with major depressive disorder.

Geber C, Ostad Haji E, Schlicht K, Hiemke C, Tadić A.

Ther Drug Monit. 2013 Jun;35(3):279-82. doi: 10.1097/FTD.0b013e31828816e0.

PMID:
23666577
17.

Safety and acceptability of practice-nurse-managed care of depression in patients with diabetes or heart disease in the Australian TrueBlue study.

Schlicht K, Morgan MA, Fuller J, Coates MJ, Dunbar JA.

BMJ Open. 2013 Apr 8;3(4). pii: e002195. doi: 10.1136/bmjopen-2012-002195. Print 2013.

18.

The TrueBlue model of collaborative care using practice nurses as case managers for depression alongside diabetes or heart disease: a randomised trial.

Morgan MA, Coates MJ, Dunbar JA, Reddy P, Schlicht K, Fuller J.

BMJ Open. 2013 Jan 24;3(1). pii: e002171. doi: 10.1136/bmjopen-2012-002171.

19.

Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.

Dreimüller N, Schlicht KF, Wagner S, Peetz D, Borysenko L, Hiemke C, Lieb K, Tadić A.

Neuropharmacology. 2012 Jan;62(1):264-9. doi: 10.1016/j.neuropharm.2011.07.017. Epub 2011 Jul 22.

PMID:
21803060
20.

WITHDRAWN: Association analysis between the early change of serum brain-derived neurotrophic factor (sBDNF) and final change of depression severity during antidepressant treatment: A pilot study.

Tadić A, Wagner S, Schlicht KF, Peetz D, Borysenko L, Krannich D, Bernius A, Hiemke C, Lieb K.

Eur Neuropsychopharmacol. 2010 Dec 13. [Epub ahead of print]

PMID:
20888738

Supplemental Content

Loading ...
Support Center